Loading company…
Talking Medicines Limited offers AI-driven healthcare marketing insight through its Drug-GPT data intelligence platform.
Founded in 2013 and headquartered in Glasgow, UK, Talking Medicines Limited sells subscription access to Drug-GPT, which turns unstructured conversational data into insights for message alignment, persona development and audience intelligence. Clients include healthcare agencies and pharmaceutical companies on yearly or multi-year contracts. In February 2022 the company raised GBP 1.5 million in a grant funding round with investors including SIS Ventures, Scottish Enterprise, Tern and Thairm Bio.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in